Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Care TwentyoneTSE:2373 +0.25%59 EV-to-EBIT is 26.67 as of Aug. 27, 2026, which is 19% above its 10-year median of 22.47. GuruFocus rates TSE:2373 with a GF Score™ of 59/100 and a GF Value™ of 円484.60 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 480 Healthcare Providers & Services companies, Care Twentyone ranks worse than 74.38% on this metric.
The historical rank and industry rank for Care Twentyone's EV-to-EBIT or its related term are showing as below:
TSE:2373'
s EV-to-EBIT Range Over the Past 10 Years
Min: 13.83 Med: 22.47 Max: 553.97
Current: 26.68
During the past 13 years, the highest EV-to-EBIT of Care Twentyone was 553.97. The lowest was 13.83. And the median was 22.47.
TSE:2373's EV-to-EBIT is ranked worse than 74.38% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 15.75
vs TSE:2373: 26.68
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Care Twentyone's Enterprise Value for the quarter that ended in Apr. 2026 was 円20,175 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Care Twentyone's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 was 円750 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Care Twentyone EV-to-EBIT Related Terms
Care Twentyone EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Care Twentyone's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Care Twentyone's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Care Twentyone EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Care Twentyone's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Care Twentyone's EV-to-EBIT falls into.
Care Twentyone's current Enterprise Value is 円20,012 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Care Twentyone's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 was 円750 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Care Twentyone (TSE:2373) has a EV-to-EBIT of 26.67 as of Aug. 27, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Care Twentyone and its competitors. This is 19% above median its historical median of 22.47. Over the past decade, Care Twentyone's EV-to-EBIT has ranged from 13.83 to 553.97. According to the industry distribution chart, Care Twentyone ranks #357 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 74.4%.
Is Care Twentyone's EV-to-EBIT too high?
Care Twentyone's current EV-to-EBIT of 26.67 is 19% above median its 10-year median of 22.47. Over the past 10 years, this metric has ranged from a low of 13.83 to a high of 553.97. The Healthcare Providers & Services industry median EV-to-EBIT is 15.75. Care Twentyone's value of 26.67 is 69.3% above this industry median. Based on the distribution chart, Care Twentyone ranks #357 out of 480 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Care Twentyone has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Care Twentyone's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Care Twentyone ranks #357 out of 480 companies for EV-to-EBIT. This places Care Twentyone in the lower half of its industry. The industry median EV-to-EBIT is 15.75. Care Twentyone's value of 26.67 is 69.3% above this benchmark. Historically, Care Twentyone's own EV-to-EBIT has ranged from 13.83 to 553.97 over the past decade. While the company's 10-year median is 22.47 vs. the industry median of 15.75, Care Twentyone has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.75, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Care Twentyone's current EV-to-EBIT of 26.67 is 69.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Care Twentyone and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Care Twentyone's current EV-to-EBIT is 26.67, which is 19% above median its own 10-year median of 22.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Care Twentyone stock overvalued right now?
Based on GuruFocus' analysis, Care Twentyone (TSE:2373) is currently considered Modestly Undervalued. The stock's GF Value™ is 円484.60, compared to a current price of 円408.00 — trading 15.8% below its estimated fair value. The current EV-to-EBIT is 26.67, which is 19% above median its 10-year median of 22.47 and 69.3% above the Healthcare Providers & Services industry median of 15.75. Care Twentyone's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Care Twentyone (TSE:2373), the current EV-to-EBIT is 26.67 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Care Twentyone (TSE:2373) Overvalued in 2026?
Based on GuruFocus' analysis, Care Twentyone stock appears to be undervalued.
The current stock price of 円408.00 is trading 15.8% below its estimated GF Value™ of 円484.60.
GuruFocus considers Care Twentyone to be Modestly Undervalued.
Key valuation signals for TSE:2373:
EV-to-EBIT: 26.67 (19% above median its 10-year median of 22.47)
GF Value™: 円484.60 vs. price of 円408.00 (15.8% below fair value)
Industry Position: 69.3% above the Healthcare Providers & Services median (#357 of 480)
No single metric tells the full story. See the TSE:2373 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Care Twentyone Corp provides nursing care services. It also leases and sells nursing equipment as well as operates a nursing home for the elder people. It also provides daycare homes, nursing homes, and group homes. It is also engaged in small-scale multifunctional home care, welfare equipment sales, rental and housing repair and light work contracting business. The company has two reportable segments based on its business model: In-home nursing care business; and Facility-based nursing care business. The home care business provides visiting care services, home care support services, day care services, etc. The Facility-based Nursing Care Business operates paid nursing homes and group homes.
59GF Score
Get the complete analysis for TSE:2373
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2373 has been successfully added to your 
